Login
$TARA
$2.42 +$0.04 (1.68%) After hours

$TARA SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
06 Nov 2026 QUARTERLY REPORT
06 Nov 2026 8-K: Results of Operations and Financial Condition

Expect to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial of TARA-002 in NMIBC by year-end 2026

13 Aug 2026 SCHEDULE 13G/A
11 Aug 2026 REGISTRATION STATEMENT
11 Aug 2026 QUARTERLY REPORT
11 Aug 2026 8-K: Results of Operations and Financial Condition

Expect to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial in 4Q 2026

07 Jul 2026 SCHEDULE 13G/A
01 Jul 2026 Form 4: Shefferman Jesse, Director

Received 215,687 shares by exercise or conversion ($412K) · Sold 215,687 shares ($882K) · Gave 30,000 shares as a gift

29 Jun 2026 8-K: Departure/Election of Directors or Officers; Compensation

Protara Therapeutics, Inc. (the “Company”) announced that Leonardo Viana Nicacio, M.D., Chief Medical Officer of the Company, resigned from the Company to explore other opportunities, effective as of June 26, 2026. Dr. Nicacio's duties w...

29 Jun 2026 144
16 Jun 2026 Form 4: Levy Richard S, Director

Granted 31,000 Stock Option (Right to Buy)

16 Jun 2026 Form 4: Solomon Michael Edward, Director

Granted 31,000 Stock Option (Right to Buy)

16 Jun 2026 Form 4: Smith Cynthia, Director

Granted 31,000 Stock Option (Right to Buy)

16 Jun 2026 Form 4: Sargen Gregory, Director

Granted 31,000 Stock Option (Right to Buy)

16 Jun 2026 Form 4: Huang Jane, Director

Granted 31,000 Stock Option (Right to Buy)

16 Jun 2026 Form 4: Garceau Roger, Director

Granted 31,000 Stock Option (Right to Buy)

16 Jun 2026 Form 4: Flannelly Barry P, Director

Granted 31,000 Stock Option (Right to Buy)

16 Jun 2026 Form 4: Beshar Luke M, Director

Granted 31,000 Stock Option (Right to Buy)

15 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

The Annual Meeting of Stockholders (the “Annual Meeting”) of Protara Therapeutics, Inc. (the “Company”) was held on June 12, 2026. As of April 15, 2026, the record date for the Annual Meeting, there were 55,060,500 shares of the Company’...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support